Navigation Links
The World Market for Diabetes Treatments Now Available at ReportsandReports

The World Market for Diabetes Treatments Now Available at ReportsandReports -- DALLAS, October 14, 2010 /PRNewswire/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Publishing & Information Services, Biotechnology, Medical Pharmaceuticals, New Products & Services Click to view news release full screen  

The World Market for Diabetes Treatments Now Available at ReportsandReports


DALLAS, October 14, 2010 /PRNewswire/ --

- ReportsandReports Announces it Will Carry The World Market for Diabetes Treatments Research Report in its Store

Browse the complete Report on: treatments.html

This Kalorama Information report , The World Market for Diabetes Treatments, provides market estimates and forecasts for the world market for diabetes treatments. The diabetes market is one of the fastest growing markets within the pharmaceutical sector, and is one of the few pharmaceutical sectors that is likely to continue to grow at double digit rates throughout the forecast period. Major contributing factors to growth are increasing obesity and an aging worldwide population. The total market for diabetes treatments is divided into two major segments:

- Insulin Markets in US, Europe, Japan, ROW - Oral Hypoglycemics in US, Europe, Japan, ROW

For each of these market segments the report provides market share and regional breakout (US, Europe, Asia, ROW). The report also discusses treatment for diabetes complications and natural and herbal treatments.

The report's geographic scope is worldwide with information for specific geographical regions; world demographics; life expectancy by country, and other general issues affecting the market. Trends covered in the report include:

- New Products and the Development Pipeline (Afrezza, Bydureon, Syncria, AVE0010, Balaglitazone, Metgluna Otelixizumab and others) - Transplantation Research Efforts - B-Cell Transplantation Research - Potential New Drug for Type 2 Diabetes - Insulin Pills - Three-month Insulin Shot - Outsourcing of Diabetes Projects - Reclassification of Cause of Death

Information is presented as a worldwide overview, with special emphasis on the U.S., Europe, and other key markets.

A market summary includes market analysis by product and region and a competitive analysis of leading providers. Additionally, key company profiles are included, including profiles of the following:

- Amylin Pharmaceuticals - AstraZeneca - GlaxoSmithKline - Eli Lilly & Co. - Merck - Metabolex, Inc. - Novo Nordisk A/S - Pfizer Inc. - Sanofi-Aventis Group - Takeda Pharmaceutical Company Limited

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information.

For the purpose of this study, Kalorama Information conducted interviews with more than 25 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.




(Due to the length of these URLs, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

All market data pertains to the world market at the manufacturers' level. The base year for data was 2009. Historical data was provided for the years 2008, with forecast data provided for 2010 through 2015. Compound annual growth rates (CAGRs) are provided for 2008-2015 periods for each region and/or segment covered. Competitive analysis is provided for the year 2009. The forecasted market analysis for 2009-2015 was largely based on demographic trends, new developments, innovative technology and global expansion.

Browse all Healthcare Reports at Browse All Specific Markets: Browse All Country Reports: Browse All Cancer Vaccine Reports:

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact: Ms. Sunita 7557 Rambler road, Suite 727, Dallas, TX 75231 Tel: +1-888-989-8004

SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. UBC, Max Planck formalize partnership among worlds top quantum physicists
2. Epitomics, Inc. Announces Worldwide Availability of LRRK2 Antibodies Developed in Partnership With The Michael J. Fox Foundation
3. UCLA chemists, engineers achieve world record with high-speed graphene transistors
4. Ion Torrent Selected as World Economic Forum Technology Pioneer
5. Enerkem Announces Construction Start of Worlds First Municipal Waste-to-Biofuels Facility in Edmonton, Alberta
6. Dr. Kyong S. Choe Recognized by Strathmores Whos Who Worldwide Publication
7. Seeing the world with new eyes: Biosynthetic corneas restore vision in humans
8. bioserie Introduces the Worlds First Made of Plants iPhone 4 Cover
9. Regenicin Completes Acquisition of Worldwide Exclusive Know-How Technology License from Lonza Walkersville
10. The nano world of Shrinky Dinks
11. New Test Centre in India: TUV Rheinland Continues Worldwide Investment Programme for Solar Industry
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 According to two new ... 2005. This is something that many doctors, scientists, and public ... questions remains: with fewer PSA tests being done, will there ... Dr. David Samadi, "Despite the efforts made ... remains the second leading cancer cause of death in men, ...
(Date:11/23/2015)... China Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing, and stem ... results for the second quarter and first half of ... --> --> Second Quarter of ... quarter of fiscal 2016 increased by 12.7% to RMB171.5 ...
(Date:11/23/2015)... The royalty-free a greement ... develop daclatasvir for 112 low- and m ... --> --> The Medicines Patent Pool (MPP) ... signing an agreement with Bristol-Myers Squibb for daclatasvir, a novel ... of the HCV virus.  The royalty-free licence will enable generic ...
(Date:11/23/2015)...  CryoLife, Inc. (NYSE: CRY ), a leading medical ... surgery, announced today that it will participate in the upcoming ... December 2, 2015 at The New York Palace Hotel in ... Mackin , President and Chief Executive Officer. --> ... --> A live webcast of the Company,s presentation ...
Breaking Biology Technology:
(Date:11/10/2015)... 2015  In this report, the biomarkers ... product, type, application, disease indication, and geography. ... are consumables, services, software. The type segments ... efficacy biomarkers, and validation biomarkers. The applications ... development, drug discovery and development, personalized medicine, ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
Breaking Biology News(10 mins):